Tuttle Capital Management LLC Grows Stock Holdings in Danaher Corporation $DHR

Tuttle Capital Management LLC boosted its stake in Danaher Corporation (NYSE:DHR) by 14.9% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,679 shares of the conglomerate’s stock after acquiring an additional 348 shares during the period. Danaher accounts for about 2.2% of Tuttle Capital Management LLC’s holdings, making the stock its 24th biggest position. Tuttle Capital Management LLC’s holdings in Danaher were worth $529,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds also recently added to or reduced their stakes in DHR. Hills Bank & Trust Co lifted its holdings in shares of Danaher by 0.3% during the first quarter. Hills Bank & Trust Co now owns 18,015 shares of the conglomerate’s stock worth $3,693,000 after purchasing an additional 53 shares during the period. Worth Financial Advisory Group LLC boosted its holdings in shares of Danaher by 4.6% in the second quarter. Worth Financial Advisory Group LLC now owns 1,195 shares of the conglomerate’s stock valued at $236,000 after acquiring an additional 53 shares in the last quarter. Sageworth Trust Co increased its stake in shares of Danaher by 2.3% during the first quarter. Sageworth Trust Co now owns 2,404 shares of the conglomerate’s stock worth $493,000 after acquiring an additional 54 shares during the period. 1834 Investment Advisors Co. raised its holdings in Danaher by 3.3% during the first quarter. 1834 Investment Advisors Co. now owns 1,666 shares of the conglomerate’s stock worth $342,000 after purchasing an additional 54 shares in the last quarter. Finally, Bruce G. Allen Investments LLC lifted its position in Danaher by 13.1% in the second quarter. Bruce G. Allen Investments LLC now owns 467 shares of the conglomerate’s stock valued at $92,000 after purchasing an additional 54 shares during the period. 79.05% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Danaher

In other Danaher news, Director Teri List sold 2,778 shares of Danaher stock in a transaction on Friday, August 22nd. The shares were sold at an average price of $211.06, for a total value of $586,324.68. Following the transaction, the director owned 20,751 shares in the company, valued at $4,379,706.06. This trade represents a 11.81% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Insiders own 11.20% of the company’s stock.

Danaher Trading Up 0.5%

Danaher stock opened at $206.19 on Wednesday. The company has a current ratio of 1.62, a quick ratio of 1.22 and a debt-to-equity ratio of 0.32. The stock has a market cap of $147.64 billion, a PE ratio of 43.87, a P/E/G ratio of 2.92 and a beta of 0.77. The stock has a 50-day moving average price of $200.96 and a 200 day moving average price of $197.13. Danaher Corporation has a 52 week low of $171.00 and a 52 week high of $279.41.

Danaher (NYSE:DHR) last released its earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 EPS for the quarter, topping the consensus estimate of $1.64 by $0.16. The firm had revenue of $5.94 billion during the quarter, compared to analysts’ expectations of $5.83 billion. Danaher had a net margin of 14.21% and a return on equity of 10.70%. Danaher’s revenue for the quarter was up 3.4% on a year-over-year basis. During the same period in the previous year, the company earned $1.72 EPS. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Equities research analysts predict that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be given a $0.32 dividend. The ex-dividend date of this dividend is Friday, September 26th. This represents a $1.28 annualized dividend and a dividend yield of 0.6%. Danaher’s dividend payout ratio (DPR) is currently 27.23%.

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on the company. Barclays reissued an “overweight” rating and set a $225.00 target price (up from $215.00) on shares of Danaher in a research note on Tuesday, June 24th. UBS Group lowered their price target on shares of Danaher from $240.00 to $225.00 and set a “buy” rating on the stock in a research note on Wednesday, July 23rd. Royal Bank Of Canada set a $241.00 price target on shares of Danaher in a report on Tuesday, September 2nd. Wall Street Zen raised shares of Danaher from a “hold” rating to a “buy” rating in a report on Friday, June 27th. Finally, Guggenheim reaffirmed a “buy” rating and issued a $250.00 price objective on shares of Danaher in a research note on Wednesday, July 23rd. Seventeen analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. According to data from MarketBeat.com, Danaher presently has an average rating of “Moderate Buy” and an average target price of $244.60.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.